Recombinant Antibody Production


Recombinant antibody production service combines gene synthesis with codon optimization for expression and purification of desired antibodies. The applications for recombinant antibodies (rAbs) are varied across biomedical and toxicological research. Monoclonal antibodies produced recombinantly are often used as biochemical markers, detection tools, or for developing effective therapeutic treatments that target cancer, autoimmune disorders, and a broad range of other diseases.

GENEWIZ from Azenta equips researchers with a range of flexible and tailored solutions that save valuable time and accelerate innovation.


End-to-End Solution for Recombinant Antibody Production Workflow


Customizable Solutions to Fit Your Downstream Analysis



Enter to win $1,000 towards GENEWIZ
Multiomics & Synthesis Solutions*

*Terms and conditions apply

How do recombinant antibodies work?

Recombinant antibodies (rAbs) work by recognizing and binding to individual antigenic sites on virtually any molecule, such as hormones, microbial antigens, and cell receptors.


What are recombinant monoclonal antibodies?

Recombinant antibodies are a type of monoclonal antibodies that are generated in vitro from a synthetic gene – cloning antibody genes into expression vectors without the use of a hybridoma. Read our blog post for more info.


In recombinant antibody production, monoclonal antibodies are produced artificially through genetic engineering and other related techniques. Genetically engineered antibodies are specifically valuable in scientific research due to their ability to recognize individual antigenic sites on almost any molecule including drugs, hormones, microbial antigens, and cell receptors. Recombinant antibodies that react with cancer antigens, for example, can be used to identify cancer cells in tissue samples and ultimately fuel the the development of cancer-fighting drugs and therapies.

Advantages of Recombinant Antibodies

  • Increase reproducibility, control and consistency
  • Faster production time over hybridoma technology
  • Easier to switch antibodies into a preferable format
  • Animal-free process

For more frequently asked questions (FAQs) please visit our antibody FAQ page.


Gene-to-Discovery Solutions

AAV Packaging, Custom mRNA Synthesis, Lentivirus Packaging, Recombinant Antibody Production

Features and Benefits

Reliable Provider

Reliable Provider

>95% on- time delivery

Rapid Turnaround

Rapid Turnaround

Industry-leading turnaround time starting at 3 weeks, including DNA synthesis to purified antibody

Stringent QC

Stringent QC

Multiple QC checkpoints, including protein concentration, aggregation, and purity

Tech Support

Technical Support

Ph.D. scientists available for consultation and support at every step



High-throughput antibody production and purification


* Samples must arrive at the GENEWIZ New jersey laboratory before 10:00 am EST to qualify for Same Day service.

Email | Phone (1-877-436-3949, Ext. 3)